161 related articles for article (PubMed ID: 19080117)
21. Microvessel density in head and neck squamous cell carcinoma primary tumors and its correlation with clinical staging parameters.
Lentsch EJ; Goudy S; Sosnowski J; Major S; Bumpous JM
Laryngoscope; 2006 Mar; 116(3):397-400. PubMed ID: 16540897
[TBL] [Abstract][Full Text] [Related]
22. Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors.
Czekierdowski A; Czekierdowska S; Danilos J; Czuba B; Sodowski K; Sodowska H; Szymanski M; Kotarski J
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():53-65. PubMed ID: 18955754
[TBL] [Abstract][Full Text] [Related]
23. Hepatocyte growth factor (HGF) downregulates thrombospondin 1 (TSP-1) expression in thyroid papillary carcinoma cells.
Scarpino S; Di Napoli A; Taraboletti G; Cancrini A; Ruco LP
J Pathol; 2005 Jan; 205(1):50-6. PubMed ID: 15526350
[TBL] [Abstract][Full Text] [Related]
24. The relation of p53 protein nuclear accumulation and angiogenesis in human prostatic carcinoma.
Yu EY; Yu E; Meyer GE; Brawer MK
Prostate Cancer Prostatic Dis; 1997 Sep; 1(1):39-44. PubMed ID: 12496932
[TBL] [Abstract][Full Text] [Related]
25. Midkine expression in malignant salivary gland tumors and its role in tumor angiogenesis.
Ota T; Ota K; Jono H; Fujimori H; Ueda M; Shinriki S; Sueyoshi T; Shinohara M; Ando Y
Oral Oncol; 2010 Sep; 46(9):657-61. PubMed ID: 20637680
[TBL] [Abstract][Full Text] [Related]
26. Cancerous, but not stromal, thrombospondin-2 contributes prognosis in pulmonary adenocarcinoma.
Chijiwa T; Abe Y; Inoue Y; Matsumoto H; Kawai K; Matsuyama M; Miyazaki N; Inoue H; Mukai M; Ueyama Y; Nakamura M
Oncol Rep; 2009 Aug; 22(2):279-83. PubMed ID: 19578767
[TBL] [Abstract][Full Text] [Related]
27. [The expression of inhibitor-1 of DNA binding/differentiation-1 and thrombospondin-1 in mucoepidermoid carcinoma of different malignant degree].
Yang S; Li A; Guo LJ; Yu T; Gong RG; Xu RS; Gao QH; Xuan M; Wang CM; Wang XY
Hua Xi Kou Qiang Yi Xue Za Zhi; 2008 Aug; 26(4):425-9. PubMed ID: 18780507
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of cyclooxygenase-2 in urothelial carcinoma in conjunction with tumor-associated-macrophage infiltration, hypoxia-inducible factor-1alpha expression, and tumor angiogenesis.
Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH; Chai CY
APMIS; 2009 Mar; 117(3):176-84. PubMed ID: 19245590
[TBL] [Abstract][Full Text] [Related]
29. Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density.
Kasper HU; Ebert M; Malfertheiner P; Roessner A; Kirkpatrick CJ; Wolf HK
Virchows Arch; 2001 Feb; 438(2):116-20. PubMed ID: 11253112
[TBL] [Abstract][Full Text] [Related]
30. Thrombospondin-1 (TSP-1) and Survivin (S) expression in non-Hogkin's lymphomas.
Paydas S; Ergin M; Erdogan S; Seydaoglu G; Yavuz S; Disel U
Leuk Res; 2008 Feb; 32(2):243-50. PubMed ID: 17706282
[TBL] [Abstract][Full Text] [Related]
31. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
[TBL] [Abstract][Full Text] [Related]
32. Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.
Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
J Hepatobiliary Pancreat Surg; 2009; 16(3):315-21. PubMed ID: 19259612
[TBL] [Abstract][Full Text] [Related]
33. [Correlation between blood flow velocity of feeding arteries and microvessel density of hepatocellular carcinoma].
Dong L; Zhang CS; Guan YF; Zhang Y; Zhao XF
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):538-40. PubMed ID: 16438851
[TBL] [Abstract][Full Text] [Related]
34. Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells.
Hyder SM; Liang Y; Wu J; Welbern V
Endocr Relat Cancer; 2009 Sep; 16(3):809-17. PubMed ID: 19570906
[TBL] [Abstract][Full Text] [Related]
35. Angiogenesis and cell proliferation in human craniopharyngioma xenografts in nude mice.
Xu J; You C; Zhang S; Huang S; Cai B; Wu Z; Li H
J Neurosurg; 2006 Oct; 105(4 Suppl):306-10. PubMed ID: 17328281
[TBL] [Abstract][Full Text] [Related]
36. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
Zhu DM; Li DC; Zhang ZX; Zhang XY
Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
[TBL] [Abstract][Full Text] [Related]
37. The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin.
Damber JE; Vallbo C; Albertsson P; Lennernäs B; Norrby K
Cancer Chemother Pharmacol; 2006 Sep; 58(3):354-60. PubMed ID: 16333676
[TBL] [Abstract][Full Text] [Related]
38. Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma.
Zhang J; Ito R; Oue N; Zhu X; Kitadai Y; Yoshida K; Nakayama H; Yasui W
Virchows Arch; 2003 Jun; 442(6):563-8. PubMed ID: 12719977
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1.
Aspiotis M; Tsanou E; Gorezis S; Ioachim E; Skyrlas A; Stefaniotou M; Malamou-Mitsi V
Eye (Lond); 2007 Aug; 21(8):1095-101. PubMed ID: 16823458
[TBL] [Abstract][Full Text] [Related]
40. Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo.
Fontana A; Filleur S; Guglielmi J; Frappart L; Bruno-Bossio G; Boissier S; Cabon F; Clézardin P
Int J Cancer; 2005 Sep; 116(5):686-91. PubMed ID: 15838828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
